Danaher Co. (NYSE:DHR) Shares Sold by Bath Savings Trust Co

Bath Savings Trust Co lowered its position in Danaher Co. (NYSE:DHR) by 4.1% during the fourth quarter, HoldingsChannel.com reports. The fund owned 72,839 shares of the conglomerate’s stock after selling 3,095 shares during the quarter. Danaher accounts for approximately 1.7% of Bath Savings Trust Co’s holdings, making the stock its 20th largest holding. Bath Savings Trust Co’s holdings in Danaher were worth $16,720,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently bought and sold shares of DHR. Coronation Fund Managers Ltd. raised its position in shares of Danaher by 29.9% during the 2nd quarter. Coronation Fund Managers Ltd. now owns 6,389 shares of the conglomerate’s stock worth $1,596,000 after purchasing an additional 1,470 shares during the last quarter. Private Advisor Group LLC lifted its position in shares of Danaher by 1.7% in the second quarter. Private Advisor Group LLC now owns 43,200 shares of the conglomerate’s stock valued at $10,794,000 after acquiring an additional 733 shares in the last quarter. Acadian Asset Management LLC boosted its stake in shares of Danaher by 419.4% during the second quarter. Acadian Asset Management LLC now owns 19,914 shares of the conglomerate’s stock valued at $4,973,000 after acquiring an additional 16,080 shares during the last quarter. Oak Thistle LLC purchased a new stake in Danaher during the 2nd quarter worth about $363,000. Finally, Fox Hill Wealth Management raised its stake in Danaher by 25.3% in the 2nd quarter. Fox Hill Wealth Management now owns 2,410 shares of the conglomerate’s stock valued at $602,000 after purchasing an additional 487 shares during the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on DHR. Barclays lowered their price target on shares of Danaher from $285.00 to $275.00 and set an “equal weight” rating for the company in a report on Wednesday, October 23rd. Bank of America upgraded Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price target for the company in a report on Friday, December 13th. Royal Bank of Canada decreased their price objective on Danaher from $333.00 to $311.00 and set an “outperform” rating on the stock in a report on Wednesday, October 23rd. KeyCorp upped their target price on Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a research note on Wednesday, October 23rd. Finally, Scotiabank started coverage on Danaher in a research note on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 price target on the stock. Six equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $286.80.

Danaher Stock Up 0.4 %

NYSE:DHR traded up $1.02 during trading hours on Tuesday, hitting $239.22. The stock had a trading volume of 1,332,915 shares, compared to its average volume of 2,527,512. The business has a 50 day simple moving average of $236.25 and a two-hundred day simple moving average of $254.22. Danaher Co. has a 1-year low of $222.53 and a 1-year high of $281.70. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The company has a market cap of $172.78 billion, a PE ratio of 45.65, a price-to-earnings-growth ratio of 4.33 and a beta of 0.83.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.57 by $0.14. The firm had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The firm’s quarterly revenue was up 3.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.02 EPS. Analysts predict that Danaher Co. will post 7.5 EPS for the current year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Friday, December 27th will be paid a dividend of $0.27 per share. The ex-dividend date of this dividend is Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a yield of 0.45%. Danaher’s dividend payout ratio (DPR) is presently 20.61%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.